{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:06:17Z","timestamp":1779807977298,"version":"3.53.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-00557741"],"award-info":[{"award-number":["RS-2025-00557741"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-16066707"],"award-info":[{"award-number":["RS-2025-16066707"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40261-026-01550-2","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:46:25Z","timestamp":1776347185000},"page":"583-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Topical Anticholinergics in the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"46","author":[{"given":"Jiah","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4796-8564","authenticated-orcid":false,"given":"Nayoung","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9479-5283","authenticated-orcid":false,"given":"Hyunji","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-887X","authenticated-orcid":false,"given":"Younghwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0587-8432","authenticated-orcid":false,"given":"Eun Jung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4595-9376","authenticated-orcid":false,"given":"Christine E.","family":"Staatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9538-0565","authenticated-orcid":false,"given":"In-hwan","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"3","key":"1550_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3238\/arztebl.2009.0032","volume":"106","author":"T Schlereth","year":"2009","unstructured":"Schlereth T, Dieterich M, Birklein F. Hyperhidrosis\u2014causes and treatment of enhanced sweating. Dtsch Arztebl Int. 2009;106(3):32\u20137. https:\/\/doi.org\/10.3238\/arztebl.2009.0032.","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"1550_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s13555-022-00885-w","volume":"13","author":"J Wohlrab","year":"2023","unstructured":"Wohlrab J, Bechara FG, Schick C, Naumann M. Hyperhidrosis: a central nervous dysfunction of sweat secretion. Dermatol Ther. 2023;13(2):453\u201363. https:\/\/doi.org\/10.1007\/s13555-022-00885-w.","journal-title":"Dermatol Ther"},{"issue":"4","key":"1550_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jaad.2010.03.013","volume":"64","author":"HW Walling","year":"2011","unstructured":"Walling HW. Clinical differentiation of primary from secondary hyperhidrosis. J Am Acad Dermatol. 2011;64(4):690\u20135. https:\/\/doi.org\/10.1016\/j.jaad.2010.03.013.","journal-title":"J Am Acad Dermatol"},{"issue":"1 Spec No.","key":"1550_CR4","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1111\/j.1524-4725.2006.32334.x","volume":"33","author":"W Lear","year":"2007","unstructured":"Lear W, Kessler E, Solish N, Glaser DA. An epidemiological study of hyperhidrosis. Dermatol Surg. 2007;33(1 Spec No.):S69-75. https:\/\/doi.org\/10.1111\/j.1524-4725.2006.32334.x.","journal-title":"Dermatol Surg"},{"issue":"2","key":"1550_CR5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaad.2003.12.029","volume":"51","author":"J Hornberger","year":"2004","unstructured":"Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51(2):274\u201386. https:\/\/doi.org\/10.1016\/j.jaad.2003.12.029.","journal-title":"J Am Acad Dermatol"},{"key":"1550_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-025-04909-6","author":"J Sun","year":"2025","unstructured":"Sun J, Chen S, Yang T, Huang L, Tang J, Feng Y, et al. Efficacy and safety of Botulinum Toxin Type A in primary axillary hyperhidrosis: a meta-analysis and systematic review. Aesthetic Plast Surg. 2025. https:\/\/doi.org\/10.1007\/s00266-025-04909-6.","journal-title":"Aesthetic Plast Surg"},{"issue":"4","key":"1550_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153719","volume":"11","author":"Y Liu","year":"2016","unstructured":"Liu Y, Bahar R, Kalia S, Huang RY, Phillips A, Su M, et al. Hyperhidrosis prevalence and demographical characteristics in dermatology outpatients in Shanghai and Vancouver. PLoS ONE. 2016;11(4):e0153719. https:\/\/doi.org\/10.1371\/journal.pone.0153719.","journal-title":"PLoS ONE"},{"issue":"3","key":"1550_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00403-022-02365-9","volume":"315","author":"T Fujimoto","year":"2023","unstructured":"Fujimoto T, Inose Y, Nakamura H, Kikukawa Y. Questionnaire-based epidemiological survey of primary focal hyperhidrosis and survey on current medical management of primary axillary hyperhidrosis in Japan. Arch Dermatol Res. 2023;315(3):409\u201317. https:\/\/doi.org\/10.1007\/s00403-022-02365-9.","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"1550_CR9","doi-asserted-by":"publisher","DOI":"10.5812\/jamm-120639","volume":"10","author":"A Dadarkhah","year":"2022","unstructured":"Dadarkhah A, Asgharpour MA. A review of hyperhidrosis treatment methods. J Arch Mil Med. 2022;10(3):e120639. https:\/\/doi.org\/10.5812\/jamm-120639.","journal-title":"J Arch Mil Med"},{"issue":"4","key":"1550_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.det.2014.06.008","volume":"32","author":"DM Pariser","year":"2014","unstructured":"Pariser DM, Ballard A. Topical therapies in hyperhidrosis care. Dermatol Clin. 2014;32(4):485\u201390. https:\/\/doi.org\/10.1016\/j.det.2014.06.008.","journal-title":"Dermatol Clin"},{"issue":"5","key":"1550_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s40257-022-00707-x","volume":"23","author":"MA Henning","year":"2022","unstructured":"Henning MA, Bouazzi D, Jemec GB. Treatment of hyperhidrosis: an update. Am J Clin Dermatol. 2022;23(5):635\u201346. https:\/\/doi.org\/10.1007\/s40257-022-00707-x.","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"1550_CR12","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1080\/14656566.2022.2083499","volume":"23","author":"A Campanati","year":"2022","unstructured":"Campanati A, Gregoriou S, Milia-Argyti A, Kontochristopoulos G, Radi G, Diotallevi F, et al. The pharmacological treatment and management of hyperhidrosis. Expert Opin Pharmacother. 2022;23(10):1217\u201331. https:\/\/doi.org\/10.1080\/14656566.2022.2083499.","journal-title":"Expert Opin Pharmacother"},{"key":"1550_CR13","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2025-3-2","volume":"14","author":"M Maazi","year":"2025","unstructured":"Maazi M, Leung AK, Lam JM. Primary hyperhidrosis: an updated review. Drugs Context. 2025;14:2025\u20133\u20132. https:\/\/doi.org\/10.7573\/dic.2025-3-2.","journal-title":"Drugs Context"},{"issue":"1","key":"1550_CR14","doi-asserted-by":"publisher","first-page":"2441258","DOI":"10.1080\/09546634.2024.2441258","volume":"36","author":"RM Odat","year":"2025","unstructured":"Odat RM, Yousef Aldalati A, Hammadeh BM, Mohammad Hussein A, Idrees M, Marzouk H, et al. Efficacy and safety of sofpironium in treatment of primary hyperhidrosis: a systematic review. J Dermatolog Treat. 2025;36(1):2441258. https:\/\/doi.org\/10.1080\/09546634.2024.2441258.","journal-title":"J Dermatolog Treat"},{"issue":"9","key":"1550_CR15","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.2340\/00015555-2731","volume":"97","author":"O Artzi","year":"2017","unstructured":"Artzi O, Loizides C, Zur E, Sprecher E. Topical oxybutynin 10% gel for the treatment of primary focal hyperhidrosis: a randomized double-blind placebo-controlled split area study. Acta Derm Venereol. 2017;97(9):1120\u20134. https:\/\/doi.org\/10.2340\/00015555-2731.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"1550_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/jdv.14651","volume":"32","author":"A Nasir","year":"2018","unstructured":"Nasir A, Bissonnette R, Maari C, DuBois J, Pene Dumitrescu T, Haddad J, et al. A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied umeclidinium in subjects with primary axillary hyperhidrosis. J Eur Acad Dermatol Venereol. 2018;32(1):145\u201351. https:\/\/doi.org\/10.1111\/jdv.14651.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1550_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s44337-024-00158-9","volume":"1","author":"EA Nada","year":"2024","unstructured":"Nada EA, Helal AA, Kaddorah MEA, Hesn MM, Hasan SY, Daniel JOI, et al. Safety and efficacy of glycopyrronium tosylate in patients with primary axillary hyperhidrosis: a systematic review and meta-analysis. Discov Med. 2024;1(1):159. https:\/\/doi.org\/10.1007\/s44337-024-00158-9.","journal-title":"Discov Med"},{"issue":"8","key":"1550_CR18","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00403-023-02587-5","volume":"315","author":"M El-Samahy","year":"2023","unstructured":"El-Samahy M, Mouffokes A, Badawy MM, Amro S, Fayad T, Abdelwahab OA. Safety and efficacy of oxybutynin in patients with hyperhidrosis: systematic review and meta-analysis of randomized controlled trials. Arch Dermatol Res. 2023;315(8):2215\u201326. https:\/\/doi.org\/10.1007\/s00403-023-02587-5.","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"1550_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74430-4","volume":"14","author":"A Elrosasy","year":"2024","unstructured":"Elrosasy A, Zeid MA, Samha R, Alkousheh H, Cadri S, Cadri N, et al. Efficacy and safety of topical glycopyrronium bromide in treating axillary hyperhidrosis: systematic review and meta-analysis. Sci Rep. 2024;14(1):24537. https:\/\/doi.org\/10.1038\/s41598-024-74430-4.","journal-title":"Sci Rep"},{"key":"1550_CR20","doi-asserted-by":"publisher","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions; 2019. https:\/\/doi.org\/10.1002\/9781119536604","DOI":"10.1002\/9781119536604"},{"issue":"1","key":"1550_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"1550_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13. https:\/\/doi.org\/10.1186\/1471-2288-5-13.","journal-title":"BMC Med Res Methodol"},{"key":"1550_CR23","unstructured":"Higgins JP, Lasserson T, Chandler J, Tovey D, Churchill R. Methodological expectations of Cochrane intervention reviews. London, UK: Cochrane. Available from: https:\/\/community.cochrane.org\/mecir-manual. Accessed Sep 27, 2024."},{"issue":"1","key":"1550_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/1346-8138.16188","volume":"49","author":"H Yokozeki","year":"2022","unstructured":"Yokozeki H, Fujimoto T, Wanatabe S, Ogawa S, Fujii C. Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: a randomized, double-blind, vehicle-controlled study. J Dermatol. 2022;49(1):86\u201394. https:\/\/doi.org\/10.1111\/1346-8138.16188.","journal-title":"J Dermatol"},{"issue":"1","key":"1550_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/bjd.18234","volume":"182","author":"C Masur","year":"2020","unstructured":"Masur C, Soeberdt M, Kilic A, Knie U, Abels C. Safety and efficacy of topical formulations containing 0\u00b75, 1 and 2% glycopyrronium bromide in patients with primary axillary hyperhidrosis: a randomized, double-blind, placebo-controlled study. Br J Dermatol. 2020;182(1):229\u201331. https:\/\/doi.org\/10.1111\/bjd.18234.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1550_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaad.2018.07.002","volume":"80","author":"DA Glaser","year":"2019","unstructured":"Glaser DA, Hebert AA, Nast A, Werschler WP, Green L, Mamelok R, et al. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials. J Am Acad Dermatol. 2019;80(1):128-38.e2. https:\/\/doi.org\/10.1016\/j.jaad.2018.07.002.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1550_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bjd.19810","volume":"185","author":"C Abels","year":"2021","unstructured":"Abels C, Soeberdt M, Kilic A, Reich H, Knie U, Jourdan C, et al. A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. Br J Dermatol. 2021;185(2):315\u201322. https:\/\/doi.org\/10.1111\/bjd.19810.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1550_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/1346-8138.15668","volume":"48","author":"H Yokozeki","year":"2021","unstructured":"Yokozeki H, Fujimoto T, Abe Y, Igarashi M, Ishikoh A, Omi T, et al. A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis. J Dermatol. 2021;48(3):279\u201388. https:\/\/doi.org\/10.1111\/1346-8138.15668.","journal-title":"J Dermatol"},{"issue":"6","key":"1550_CR29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jaad.2020.02.016","volume":"82","author":"B Kirsch","year":"2020","unstructured":"Kirsch B, Smith S, Cohen J, DuBois J, Green L, Baumann L, et al. Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: a phase II, randomized, controlled, double-blinded trial. J Am Acad Dermatol. 2020;82(6):1321\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2020.02.016.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1550_CR30","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1524-4725.2007.33192.x","volume":"33","author":"N Solish","year":"2007","unstructured":"Solish N, Bertucci V, Dansereau A, Hong HC, Lynde C, Lupin M, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg. 2007;33(8):908\u201323. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.33192.x.","journal-title":"Dermatol Surg"},{"issue":"4","key":"1550_CR31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ad.2023.09.006","volume":"115","author":"D Morgado-Carrasco","year":"2024","unstructured":"Morgado-Carrasco D, de Lucas R. Topical anticholinergics in the management of focal hyperhidrosis in adults and children. A narrative review. Actas Dermosifiliogr. 2024;115(4):356\u201367. https:\/\/doi.org\/10.1016\/j.ad.2023.09.006.","journal-title":"Actas Dermosifiliogr"},{"issue":"4","key":"1550_CR32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.36849\/JDD.2021.5569","volume":"20","author":"J Hobart","year":"2021","unstructured":"Hobart J, Burke L, Kirsch B, Chadha D. Hyperhidrosis disease severity measure-axillary (HDSM-Ax): evaluation of measurement performance. J Drugs Dermatol. 2021;20(4):410\u20138. https:\/\/doi.org\/10.36849\/JDD.2021.5569.","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"1550_CR33","first-page":"707","volume":"17","author":"BM Kirsch","year":"2018","unstructured":"Kirsch BM, Burke L, Hobart J, Angulo D, Walker PS. The Hyperhidrosis Disease Severity Measure-Axillary: conceptualization and development of item content. J Drugs Dermatol. 2018;17(7):707\u201314.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"1550_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/cc11919","volume":"17","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care. 2013;17(1):R2. https:\/\/doi.org\/10.1186\/cc11919.","journal-title":"Crit Care"},{"issue":"1","key":"1550_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000365390","volume":"230","author":"MK Basra","year":"2015","unstructured":"Basra MK, Salek MS, Camilleri L, Sturkey R, Finlay AY. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology. 2015;230(1):27\u201333. https:\/\/doi.org\/10.1159\/000365390.","journal-title":"Dermatology"},{"key":"1550_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-981-33-6009-9_2","volume-title":"Introduction to basics of pharmacology and toxicology: Volume 2: essentials of systemic pharmacology: from principles to practice","author":"M Lakshmanan","year":"2021","unstructured":"Lakshmanan M. Cholinoceptor antagonists. In: Introduction to basics of pharmacology and toxicology: Volume 2: essentials of systemic pharmacology: from principles to practice. Singapore: Springer; 2021. p. 25\u201340."},{"issue":"12","key":"1550_CR37","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1007\/s13555-022-00838-3","volume":"12","author":"NS Wong","year":"2022","unstructured":"Wong NS, Adlam TM, Potts GA, Farshchian M. Hyperhidrosis: a review of recent advances in treatment with topical anticholinergics. Dermatol Ther. 2022;12(12):2705\u201314. https:\/\/doi.org\/10.1007\/s13555-022-00838-3.","journal-title":"Dermatol Ther"},{"issue":"9","key":"1550_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204056","volume":"13","author":"L Lin","year":"2018","unstructured":"Lin L. Bias caused by sampling error in meta-analysis with small sample sizes. PLoS ONE. 2018;13(9):e0204056. https:\/\/doi.org\/10.1371\/journal.pone.0204056.","journal-title":"PLoS ONE"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01550-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-026-01550-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01550-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:48:28Z","timestamp":1779806908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-026-01550-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1550"],"URL":"https:\/\/doi.org\/10.1007\/s40261-026-01550-2","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jiah Kim, Nayoung Han, Hyunji Koo, Younghwa Kim, Eun Jung Hwang, and In-hwan Baek declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript. Christine E. Staatz is an Editorial Board member of Clinical Drug Investigation. Christine E. Staatz was not involved in the selection of peer reviewers for this manuscript nor in any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (RS-2025-00557741, RS-2025-16066707). The funding body had no role in the study design, data collection, analysis, interpretation of the data, or writing of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Conceptualization: Jiah Kim, In-hwan Baek; Data curation: Jiah Kim, Nayoung Han, In-hwan Baek; Formal analysis: Jiah Kim, Nayoung Han, In-hwan Baek; Funding acquisition: Younghwa Kim; Investigation: Jiah Kim, Nayoung Han, Hyunji Koo, Younghwa Kim, Eun Jung Hwang, Min-Soo Kim, Christine E. Staatz, In-hwan Baek; Methodology: Jiah Kim, Nayoung Han, In-hwan Baek; Software: Jiah Kim, Nayoung Han, In-hwan Baek; Supervision: Nayoung Han, Hyunji Koo, Younghwa Kim, Eun Jung Hwang, Min-Soo Kim, Christine E. Staatz; Validation: Nayoung Han, Hyunji Koo, Younghwa Kim, Eun Jung Hwang, Min-Soo Kim, Christine E. Staatz; Writing \u2013 original draft: Jiah Kim, In-hwan Baek; Writing \u2013 review & editing: Nayoung Han, Hyunji Koo, Younghwa Kim, Eun Jung Hwang, Min-Soo Kim, Christine E. Staatz. All authors read and approved the final version of the manuscript and agree to be accountable for all aspects of the work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' Contributions"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}